About
Rick Dewey joined Versant Ventures in 2024 as an Entrepreneur-in-Residence with over 15 years translating human genome insights into new medicines. He previously was Chief Scientific Officer of Foresite Labs and Head of Translational Genetics at Regeneron Genetics Center, and is a board-certified physician-scientist trained at Stanford.
Colleagues at Versant Ventures
Alex Mayweg
Managing Director at Versant Ventures
Alicia Levey
Venture Partner at Versant Ventures
Andrew Jefferson
Operating Partner at Versant Ventures
Ariel Kantor
Principal at Versant Ventures
Barbara Lubash
Managing Director at Versant Ventures
Beckie Robertson
Managing Director at Versant Ventures
Bill Link
Investor at Versant Ventures
Brad Bolzon
Chairman, Managing Director at Versant Ventures